 |
PDBsum entry 1ev3
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hormone/growth factor
|
PDB id
|
|
|
|
1ev3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Acta Crystallogr D Biol Crystallogr
56:1541-1548
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
R6 hexameric insulin complexed with m-cresol or resorcinol.
|
|
G.D.Smith,
E.Ciszak,
L.A.Magrum,
W.A.Pangborn,
R.H.Blessing.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structures of three R(6) human insulin hexamers have been determined.
Crystals of monoclinic m-cresol-insulin, monoclinic resorcinol-insulin and
rhombohedral m-cresol-insulin diffracted to 1. 9, 1.9 and 1.78 A, respectively,
and have been refined to residuals of 0.195, 0.179 and 0.200, respectively. In
all three structures, a phenolic derivative is found to occupy the phenolic
binding site, where it forms hydrogen bonds to the carbonyl O atom of CysA6 and
the N atom of CysA11. Two additional phenolic derivative binding sites were
identified within or between hexamers. The structures of all three hexamers are
nearly identical, although a large displacement of the N-terminus of one B chain
in both monoclinic structures results from coordination to a sodium ion which is
located between symmetry-related hexamers. Other minor differences in structure
arise from differences in packing in the monoclinic cell compared with the
rhombohedral cell. Based upon the differences in conformation of the GluB13 side
chains in T(6), T(3)R(f)(3) and R(6) hexamers, the deprotonation of these side
chains appears to be associated with the T-->R conformational transition.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 3.
Figure 3 SETOR drawing (Evans, 1993[Evans, S. V. (1993). J. Mol.
Graph. 6, 244-245.]) of B chain Glu13 residues in (a) T[6] human
insulin, (b) T[3]R human
insulin, (c) monoclinic m-cresol human insulin, (d) monoclinic
resorcinol human insulin and (e) rhombohedral m-cresol human
insulin.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from the IUCr:
Acta Crystallogr D Biol Crystallogr
(2000,
56,
1541-1548)
copyright 2000.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Keidel,
M.Bonaccio,
N.Ghaderi,
D.Niks,
D.Borchardt,
and
M.F.Dunn
(2009).
1H[19F] NOE NMR structural signatures of the insulin R6 hexamer: evidence of a capped HisB10 site in aryl- and arylacryloyl-carboxylate complexes.
|
| |
Chembiochem,
10,
450-453.
|
 |
|
|
|
|
 |
C.Poulsen,
D.Jacobsen,
and
L.Palm
(2008).
Effect of ethylenediamine on chemical degradation of insulin aspart in pharmaceutical solutions.
|
| |
Pharm Res,
25,
2534-2544.
|
 |
|
|
|
|
 |
M.Norrman,
and
G.Schluckebier
(2007).
Crystallographic characterization of two novel crystal forms of human insulin induced by chaotropic agents and a shift in pH.
|
| |
BMC Struct Biol,
7,
83.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|